Johnson & Johnson and GlaxoSmithKline are leading research into new antibiotics - but a new report has called for further action to combat the rise of drug-resistant bacteria.<
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.